Validation of 8-[123I]iodo-L-1,2,3,4-tetrahydro-7-hydroxyisoquinoline-3-carboxylic acid as an imaging agent for prostate cancer in experimental models of human prostate cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/17210466

Download in:

View as

General Info

PMID
17210466